Showing results (21-30 of 697) with videos related to
Sort By:
Pageof 70
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 31, 2004
Contribution of PAI-1 in cardiovascular pathologyM C Alessi, I Juhan-VagueThrombosis and Haemostasis|July 1, 1997
PAI-1, obesity, insulin resistance and risk of cardiovascular eventsI Juhan-Vague, M C AlessiArteriosclerosis (Dallas, Tex.)|May 1, 1989
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase responseI Juhan-Vague, M C Alessi, P Joly, et al.Thrombosis and Haemostasis|February 23, 2002
Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesityP E Morange, D Bastelica, M F Bonzi, et al.Metabolism: Clinical and Experimental|May 1, 1992
Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysisP Vague, D Raccah, I Juhan-VagueThrombosis and Haemostasis|August 30, 1985
Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisolM F Aillaud, I Juhan-Vague, M C Alessi, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|December 1, 1993
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study GroupI Juhan-Vague, S G Thompson, J JespersenHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 15, 2001
Fat cell function and fibrinolysisM C Alessi, P Morange, I Juhan-VagueCurrent Cardiology Reports|September 12, 2000
Fibrinolytic function and coronary riskI Juhan-Vague, P Morange, M Christine AlessiJournal of Internal Medicine|March 31, 2004
Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseasesA Mavri, M-C Alessi, I Juhan-VaguePageof 70